FA

Fousiya Aboobacker

Active Director Designated Partner DIN 09843639
DIN 09843639 First appointment Sep 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Fousiya Aboobacker

Data last updated:

Fousiya Aboobacker is a Designated Partner at Al Shahama Hospital And Research Centre Llp (since 2022). The company operates in Healthcare.

DIN 09843639
Primary Designation Designated Partner
Industry Healthcare
First Appointment 06 Sep 2022
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner06 Sep 20222019Active

Board colleagues of Fousiya Aboobacker

NameDINCompanyDesignation
Abdulazeez Kodiyil Thodi08399672Al Shahama Hospital And Research Centre LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Al Shahama Hospital And Research Centre Llp
Premium access

Shareholding and investment profile for Fousiya Aboobacker

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Fousiya Aboobacker

Fousiya Aboobacker currently holds 1 directorship: Al Shahama Hospital And Research Centre Llp (Designated Partner, since 06 Sep 2022).

Fousiya Aboobacker was first appointed on 06 Sep 2022 as Designated Partner at Al Shahama Hospital And Research Centre Llp.

The current boards of Fousiya Aboobacker's companies include Abdulazeez Kodiyil Thodi (Al Shahama Hospital And Research Centre Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available